Cardiology
Verona Pharma submits FDA New Drug Application for COPD treatment
June 27, 2023Research and Development COPD, Cardiology, FDA, ensifentrine, new drug application, verona pharma
UK-based Verona Pharma has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug …
Bellerophon shares top-line data from phase 3 trial of INOpulse for fILD
June 6, 2023Medical Communications Bellerophon Therapeutics, Cardiology, clinical trials, fibrotic interstitial lung disease
Bellerophon Therapeutics has announced top-line results from its phase 3 REBUILD trial evaluating the safety and efficacy of INOpulse for …
NICE approves first treatment for obstructive HCM for NHS use
June 2, 2023Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM
The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …
Pharmanovia and Stealth BioTherapeutics enter new licensing agreement for novel Barth syndrome treatment
May 31, 2023Sales and Marketing Barth syndrome, Cardiology, Pharmanovia, Stealth BioTherapeutics, licensing agreement
Pharmanovia and Stealth BioTherapeutics have announced that they have entered into a new licensing agreement for the marketing and further …
Pulse Medical receives FDA BDD for its μFR system
May 30, 2023Medical Communications BDD, Cardiology, FDA, Pulse Medical
Shanghai, China-based Pulse Medical Technology has announced that its 4th generation μFR system has received Breakthrough Device Designation (BDD) from …
Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter
May 24, 2023Medical Communications Artivion, Baxter International, Cardiology, FDA, PMA, PerClot
US cardiac and vascular surgery company Artivion has announced that the US Food and Drug Administration (FDA) has granted a …
FDA approves Abbott’s Assert-IQ insertable cardiac monitor
May 19, 2023Research and Development Abbott, Cardiology, Devices, FDA, heart monitor, medical devices
Abbott has announced that the US Food and Drug Administration (FDA) has granted its clearance for the Assert-IQ insertable cardiac …
FDA grants Priority Review for Takeda’s cTTP treatment
May 17, 2023Research and Development Biologics License Application, Cardiology, FDA, Takeda, cTTP
Japanese biopharmaceutical company Takeda has announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application …
Bellerophon Therapeutics completes phase 3 study for fibrotic interstitial lung disease drug
May 12, 2023Medical Communications Bellerophon Therapeutics, Cardiology, clinical trial, lung disease
US clinical stage biotherapeutics company Bellerophon Therapeutics has announced that the last patient has completed its phase 3 REBUILD study, …
AstraZeneca’s Farxiga approved to reduce risk of cardiovascular death
May 9, 2023Medical Communications AstraZeneca, Cardiology, FDA, cvd, farxiga, heart failure
AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga to reduce the risk of cardiovascular …
Vicore announces initiation of proof-of-concept study for endothelial dysfunction treatments
May 4, 2023Research and Development Cardiology, Vicore Pharma, clinical trials, endothelial dysfunction, organ damage
Vicore Pharma Holding AB has announced that it has dosed the first patient with C21 in its randomised, double-blind, placebo-controlled, …
Latest content
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
